nadpricesA dated index of NAD+ prices

TeleZen MD NAD+ prices

14 figures read September 2026.

TeleZen MD publishes a standing rate of $133–$198 for NAD+, but never on a calendar month — it bills on a cycle of its own, and the difference is the whole reason this page prints the seller's own wording for it.

What TeleZen MD publishesrate, not monthly
The figure$133–$198Every one of these figures is in this seller’s page markup only — a reader does not see them on their page.
Charged oncalendar month
RouteSubQ, Nasal
ReadSeptember 2026
Price disclosure score79 of 100

See TeleZen MD’s own page

What TeleZen MD publishes

TeleZen MD publishes a standing rate, but never on a calendar month — it bills every 4 weeks, every 28 days, or across a multi-month term. Of the 11 sellers in this index that fall in the same bucket, that puts it with the 10% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.

The headline figures here do not all mean the same thing: this seller's 6 leading figures carry 5 different qualifiers between them — standing rate, “$198/month after”; standing rate, “$166/month”; standing rate, “$149/month”; standing rate, “$133/month”; standing rate, “$148/month after”. A board that printed them in one column would be comparing standing rate, so this page prints each one with the sentence that makes it true.

Every figure TeleZen MD publishes — 14 figures, read September 2026

TeleZen MD — every NAD+ figure read, September 2026
FigureWhat it isCycle, in their wordsRouteDoseRead
$98unresolved/monthnot statedNot statedSeptember 2026
$10from-priceper injectionSubQ1000mg per vialSeptember 2026
$148first periodMonthly PlanSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$198standing rate$198/month afterSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$498prepay totalQuarterly PlanSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$166standing rate$166/monthSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$898prepay totalSemi-Annual PlanSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$149standing rate$149/monthSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$1598prepay totalAnnual PlanSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$133standing rate$133/monthSubQ1000 MG/MLSeptember 2026markup only — not shown to a reader
$98first periodMonthly PlanNasal300 MG/15 MLSeptember 2026markup only — not shown to a reader
$148standing rate$148/month afterNasal300 MG/15 MLSeptember 2026markup only — not shown to a reader
$148first periodMonthly PlanNasal300 MG/30 MLSeptember 2026markup only — not shown to a reader
$198standing rate$198/month afterNasal300 MG/30 MLSeptember 2026markup only — not shown to a reader

In TeleZen MD’s own words

Price disclosure score: 79 of 100

This scores what TeleZen MD publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. TeleZen MD sits 46 of 106.

TeleZen MD — price disclosure score, 79 of 100
What is scoredWhat TeleZen MD publishesPoints
An exact figureThe headline figure is an exact charge for a defined purchase, not a floor and not a first-period rate.30of 30
A stated cadenceThe seller states the interval it bills on, so a reader knows when the next charge lands.20of 20
Visible on the page0 of 6 headline figures are visible to a reader; the rest sit in the page's markup only, where presence is not publication.0of 20
A stated routeThe seller states how the product is administered, in its own sentence.15of 15
A stated dose13 of 14 figures state the dose they buy.14of 15
Price disclosure scoreThis scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value.79of 100

What TeleZen MD does not publish

Each of these is a count over what was actually read, not an impression. 14 figures were read from this seller, and every sentence below is measured against that number.

TeleZen MD — what is stated on the figures read
  1. Figures visible to a reader on the seller’s page

    2 of 14the rest sit in the page’s markup only

  2. Figures stating a dose

    13 of 14

  3. Figures that resolve to a usable price

    13 of 14

Source: Counted over the 14 figures read from TeleZen MD’s own pages, September 2026. Each track is that figure count.

Where TeleZen MD sits

66 other sellers in this index also state a SubQ and Nasal route. Ranked with them on price disclosure, TeleZen MD is 42 of 67. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.

Boards TeleZen MD appears on

The reading record

This site has read TeleZen MD once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.

Figures are read from TeleZen MD’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.

Check TeleZen MD’s current price